These include the patients health history, how bad the B12 deficiency is, and how they react to the first treatment
In recent years, there has been increasing attention on epilepsy caused by genetic metabolic disorders
Peptide therapy with DAC is an exception, with a half-life of approximately 68 days, allowing for less frequent dosing
It quickly provides the requisite energy, and is much more effective than vitamin B12 preparations in tablet form, which have to take a detour through the stomach and intestine
It appears to do this through several mechanisms including upregulation of growth factors involved in mucosal repair, reduction of inflammatory mediators, and support of gut barrier integrity
Timeline of expected results Understanding when to expect results prevents premature protocol abandonment and helps researchers assess whether their approach is working